Limited Time OfferSave up to $400 on your first GLP-1 order
Getting Started

Your First Week on Semaglutide: A Day-by-Day Guide to What Actually Happens

Julian Mercer
Lead Bio-Systems Analyst · Updated May 2026 · 16 min read
Week 1 calendar with semaglutide pen and wellness items

You just got prescribed semaglutide. The pen is in the fridge. You have questions. When do I inject? Will I feel nauseous? How fast will it work? What should I eat? This is the no-fluff, day-by-day guide based on real patient timelines and clinical data.

Day 1: Injection Day

Your starting dose is 0.25 mg — this is a sub-therapeutic "onboarding" dose designed to let your body acclimate. It will not produce significant weight loss on its own. That is intentional.

  • Where to inject: Abdomen, thigh, or upper arm. Rotate sites each week.
  • When to inject: Any time of day. Timing doesn't matter clinically — just pick a consistent day.
  • Pain level: Minimal. The needle is 31-gauge (thinner than an acupuncture needle). Most patients describe it as a brief pinch.
  • What you feel: Usually nothing for the first 6–12 hours.

Days 2–3: First Effects

This is when GLP-1's appetite suppression starts to manifest:

  • Appetite change: You may notice you are not thinking about food as much. The "food noise" — that constant background hum of cravings — starts to quiet. This is the neurological effect kicking in.
  • Mild nausea: ~20% of patients experience mild nausea in the first 48 hours. It is usually manageable. Eat small, bland meals. Stay hydrated. See our side effects management guide.
  • Fullness: You may feel full faster at meals. This is GLP-1 slowing gastric emptying — exactly what it is designed to do.

Days 4–5: Settling In

  • Nausea (if present) usually peaks day 2–3 and improves by day 4
  • Appetite suppression stabilizes — you eat smaller portions naturally
  • Energy levels may feel different — some patients report slight fatigue (eating less = fewer calories), others feel more energetic (less post-meal sluggishness)
  • Focus on high-protein meals — your body needs protein even though your appetite is reduced

Days 6–7: Pre-Second Dose

  • The first dose is wearing off — you may notice appetite returning slightly before your next injection. This is normal at 0.25 mg.
  • If you tolerated the first dose well, your clinician will keep you at 0.25 mg for 4 weeks before increasing to 0.5 mg.
  • Scale change: Do not expect it yet. Meaningful weight loss begins at 0.5–1.0 mg for most patients. The full timeline typically shows 2–4 lbs in month 1 (at 0.25 mg).

Ready for Day 1?

Complete your clinical intake today. Your TelehealthFX clinician walks you through injection technique, dose timing, and exactly what to eat in week 1.

Start Your Evaluation

Week 1 Mistakes to Avoid

  1. Eating too little. Appetite suppression does not mean you should skip meals. Your body needs 1,200+ calories minimum, with priority on protein (0.7–1.0g per lb of goal body weight). See our optimization guide.
  2. Expecting dramatic results at 0.25 mg. This dose is about tolerability, not transformation. Patience here pays off at higher doses.
  3. Not drinking enough water. GLP-1 reduces thirst cues. Force 64+ oz daily. Dehydration worsens every side effect.
  4. Skipping the post-injection walk. Light movement (15-minute walk) after injection reduces injection-site discomfort and nausea.

Frequently Asked Questions

How much weight will I lose in the first week?

At 0.25 mg, expect 0–2 lbs in week 1, mostly from reduced caloric intake. Significant weight loss (1–2 lbs/week) begins at 0.5–1.0 mg, typically weeks 5–8.

What if I feel nothing after the first injection?

Some patients feel minimal effects at 0.25 mg. This is normal and not a sign that the medication is not working. The dose will be increased at your next titration step.

Week 1 Is the Start. We Walk You Through Every Step.

Clinician-guided onboarding. No guessing. No Googling side effects at 2 AM.

Start Now

References

  1. Novo Nordisk. (2026). Wegovy (semaglutide) prescribing information: dose titration schedule.
  2. Wilding, J. P. H., et al. (2021). STEP 1: Once-weekly semaglutide in adults with overweight or obesity. NEJM, 384(11), 989–1002.